Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

CTech 24/7

More stories in CTech

Quris

7 stories about Quris

Quris-AI appoints Michel Vounatsos and Yossi Ben Amram in key roles
04.01.24|CTechVounatsos was appointed Board member and Ben Amram was appointed President, respectively.
Pharma giant Merck expands collaboration with Quris-AI
28.09.23|Meir OrbachThis follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches
SoftBank leads $9 million investment in AI pharma startup Quris
20.12.22|Meir OrbachThe Israeli startup expanded its Seed funding to $37 million and plans to use the additional investment to advance its Bio-AI clinical-prediction platform that simulates clinical trials
CTech’s Book Review: Breaking down the barriers to set you free
13.07.22|Isaac BentwichIsaac Bentwich, Founder and CEO of Quris Technologies, shares insights after reading “Untethered Soul” by Michael A. Singer
Pharma giant Merck inks deal with Israel’s Quris for clinical safety prediction
09.02.22|Meir OrbachThe Israeli company which develops predictive technology based on artificial intelligence has signed an agreement worth tens of millions of dollars to test drugs by the pharma giant
Quris closes record $28 million Seed funding for AI drug development platform
11.01.22|Meir OrbachThe Israeli startup uses AI-powered miniaturized “patients-on-a-chip” to avoid the risks and costs of failed clinical trials and eliminate the reliance on ineffective animal testing
Quris raises $9 million in Seed for its clinician prediction AI platform
21.10.21|James SpiroThe announcement coincides with the launch of its platform via a partnership with the NYSCF Research Institute.

About CTech Terms of Use Privacy Policy

Back to Top